(Q37831814)

24 August 2017

1 reference

title

Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature (English)

1 reference

amyotrophic lateral sclerosis

24 August 2017

main subject

0 references

1 reference

Melissa Padovan

1

1 reference

24 August 2017

Luisa Maria Caniatti

series ordinal

2

1 reference

24 August 2017

Francesco Trotta

series ordinal

3

1 reference

24 August 2017

Marcello Govoni

series ordinal

4

1 reference

24 August 2017

publication date

22 January 2011

1 reference

Rheumatology International

24 August 2017

published in

1 reference

24 August 2017

volume

31

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

715-719

1 reference

Adalimumab: a review of side effects

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Optic neuritis occurring with anti-tumour necrosis factor alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Tumor necrosis factor and motoneuronal degeneration: an open problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Biochemical and Clinical Aspects of Methotrexate Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Development of the anterior cingulate syndrome in a child due to delayed necrotising methotrexate leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

From Charcot to SOD1: mechanisms of selective motor neuron death in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Circulating levels of tumour necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Amyotrophic lateral sclerosis--are microglia killing motor neurons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized 'anti-TNF' therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1760-3

Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis. A puzzle illustrated by a new case.

21 January 2018

1 reference

12 December 2020

Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFalpha blockers for ankylosing spondylitis: fortuitus association or new side effect of TNFalpha blockers?

1 reference

12 December 2020

[de Gorgerot-Sjogren syndrome simulating amyotrophic lateral sclerosis]

1 reference

12 December 2020

Chloroquine neuromyopathy

1 reference

12 December 2020

Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy

1 reference

12 December 2020

Neuropsychiatric systemic lupus erythematosus presenting as amyotrophic lateral sclerosis

1 reference

12 December 2020

Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome

1 reference

12 December 2020

Soluble TNF receptors partially protect injured motoneurons in the postnatal CNS

1 reference

12 December 2020

Neurological complications of infliximab

1 reference

12 December 2020

Severe polyneuritis following gold therapy for rheumatoid arthritis

1 reference

12 December 2020

Development of amyotrophic lateral sclerosis in the course of systemic lupus erythematosus

1 reference

12 December 2020

Neurotoxicity of intrathecal methotrexate: MR imaging findings

1 reference

12 December 2020

Is TNFalpha really a good therapeutic target in motoneuronal degeneration? A case of amyotrophic lateral sclerosis in a patient with RA receiving infliximab

1 reference

12 December 2020

[Amyotrophic lateral pseudosclerosis in the course of rheumatoid disease. Report of a case]

1 reference

12 December 2020

Rheumatoid arthritis and motor neurone disease--an association?

1 reference

12 December 2020

Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease

1 reference

12 December 2020

Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports

1 reference

12 December 2020

Amyotrophic lateral sclerosis in a patient with systemic lupus erythematosus

1 reference

12 December 2020

CHLOROQUINE NEUROMYOPATHY

1 reference

12 December 2020

Apoptosis of Oligodendrocytes via Fas and TNF-R1 Is a Key Event in the Induction of Experimental Autoimmune Encephalomyelitis

1 reference

12 December 2020

[Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature]

1 reference

12 December 2020

[Epidemiology of amyotrophic lateral sclerosis].

1 reference

12 December 2020

Demyelinating events in rheumatoid arthritis after drug exposures

1 reference

12 December 2020

Misdiagnosis in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures

1 reference

12 December 2020

TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

12 December 2020

Scleroderma and motor neuron disease: an unusual association

1 reference

12 December 2020

10.1007/S00296-010-1760-3

Identifiers

DOI

1 reference

24 August 2017

1 reference